Prostate Cancer Diagnostics Market 2022 Emerging Trends, Trade Survey And Growth Opportunities 2030Posted by rahul nikade on December 4th, 2022 Prostate Cancer Diagnostics Industry Overview The global prostate cancer diagnostics market size was valued at USD 2.83 billion in 2019 and is anticipated to expand at a CAGR of 13.2% during the forecast period. Increasing prevalence of prostate cancer is one of the major factors propelling the demand for diagnostic products. According to the National Cancer Institute, in the U.S., approximately 174,650 new cases were diagnosed in 2019. Technological advancements in diagnostic tests are expected to further fuel market growth during the forecast period. According to the National Cancer Institute, researchers are currently testing the use of Artificial Intelligence (AI) to diagnose prostate cancer. AI tools are used for identifying suspicious areas seen during a Magnetic Resonance Imaging (MRI) scan that require biopsies to confirm the presence of malignant cells. Artificial intelligence tools are also being tested in order to improve biopsy sample analysis facilitated to provide more efficient and accurate results. Gather more insights about the market drivers, restrains and growth of the Global Prostate Cancer Diagnostics Market Rise in government initiatives to develop new technologies to enhance diagnosis is expected to impact the market positively. For instance, the National Cancer Institute initiated Prostate Specialized Programs of Research Excellence (SPORE)-a program designed to convert scientific findings into clinical settings based outcomes. The institute also facilitates the development of new technologies and studies to gain a better understanding of monitoring, prevention, diagnosis, and treatment. The rising number of new market entrants is another factor anticipated to fuel the growth of the prostate cancer diagnostics market in near future. For instance, in July 2018, Gregor Diagnostics, invested USD 9,00,000 to support its efforts to develop a novel at-home screening test. This device is expected to facilitate highly sensitive test results in comparison to common PSA tests. Thus, increasing investment by new entrants is expected to drive the growth significantly. However, the high cost of the tests is anticipated to hinder growth. Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.
Prostate Cancer Diagnostics Market Segmentation Grand View Research has segmented the global prostate cancer diagnostics market based on test type and region:
Market Share Insights
Key Companies profiled: Some prominent players in the global prostate cancer diagnostics market include
Order a free sample PDF of the Prostate Cancer Diagnostics Market Intelligence Study, published by Grand View Research. About Grand View Research Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc. Phone: 1-415-349-0058 Toll Free: 1-888-202-9519 Email: sales@grandviewresearch.com Web: https://www.grandviewresearch.com Like it? Share it!More by this author |